Suppliers / Aurobindo Pharma Limited, Unit I

Aurobindo Pharma Limited, Unit I

India 2 duplicate records merged Updated 9 July 2026

Aurobindo Pharma Limited, Unit I is an API manufacturer based in India. Its GMP standing is certified by EMA.

0
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Borpatla Village, India Not on file

What they file, and where

Molecule Regulators Docs
Amisulpride SFDA (Saudi Arabia) 1
Atorvastatin SFDA (Saudi Arabia) 1
Bisoprolol SFDA (Saudi Arabia) 1
Cefdinir SFDA (Saudi Arabia) 1
Cefuroxime Axetil SFDA (Saudi Arabia) 1
Entacapone SFDA (Saudi Arabia) 1
Metformin SFDA (Saudi Arabia) 1
Metoprolol SFDA (Saudi Arabia) 1
Ondansetron SFDA (Saudi Arabia) 1
Pantoprazole SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Cefdinir API Cefuroxime Axetil API Metformin API Atorvastatin API Bisoprolol API Pantoprazole API Ondansetron API Metoprolol API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Aurobindo Pharma Limited, Unit I comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates